We are live on ! Find out more
APC

Alpine Peaks Capital Portfolio holdings

AUM $85.4M
1-Year Est. Return 11.24%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
+$21.2M
Cap. Flow
+$3.66M
Cap. Flow %
2.22%
Top 10 Hldgs %
60.49%
Holding
22
New
–
Increased
11
Reduced
3
Closed
–
Avg Time Held
7.4 quarters
Top 10 Avg Time Held
4.9 quarters
Top 20 Avg Time Held
5.9 quarters

Top Buys

Rank Stock Value
1
CGNX icon
Cognex
CGNX
+$1.4M
2
USPH icon
US Physical Therapy
USPH
+$863K
3
IPAR icon
Interparfums
IPAR
+$862K
4
HEI.A icon
HEICO Corp Class A
HEI.A
+$677K
5
TREX icon
Trex
TREX
+$577K

Top Sells

Rank Stock Value
1
QLYS icon
Qualys
QLYS
+$1.38M
2
BBSI icon
Barrett Business Services
BBSI
+$1.08M
3
APH icon
Amphenol
APH
+$247K

Sector Composition

Rank Sector Weight
1 Industrials 29.58%
2 Technology 27.47%
3 Healthcare 18.73%
4 Consumer Discretionary 15.99%
5 Consumer Staples 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IPAR icon
1
Interparfums
IPAR
$3.59B
$13.5M 8.23%
94,039
+6,600
+8% +$862K
2021 Q4
8 quarters
MEDP icon
2
Medpace
MEDP
$17.1B
$12.2M 7.44%
39,929
+1,850
+5% +$499K
2021 Q4
8 quarters
ROL icon
3
Rollins
ROL
$15.4B
$11.9M 7.2%
271,475
+14,700
+6% +$572K
2022 Q1
7 quarters
EVTC icon
4
Evertec
EVTC
$1.77B
$9.51M 5.78%
232,393
+9,727
+4% +$358K
2021 Q4
8 quarters
WAB icon
5
Wabtec
WAB
$48.2B
$9.33M 5.67%
73,550
– –
2021 Q4
8 quarters
CGNX icon
6
Cognex
CGNX
$10.6B
$9.23M 5.61%
221,195
+36,500
+20% +$1.4M
2021 Q4
8 quarters
RHI icon
7
Robert Half
RHI
$3.47B
$9.11M 5.53%
103,561
+850
+0.8% +$67.6K
2021 Q4
8 quarters
USPH icon
8
US Physical Therapy
USPH
$1.26B
$8.61M 5.23%
92,437
+9,800
+12% +$863K
2021 Q4
8 quarters
QLYS icon
9
Qualys
QLYS
$7B
$8.29M 5.04%
42,245
-7,875
-16% -$1.38M
2021 Q4
8 quarters
TREX icon
10
Trex
TREX
$4.56B
$7.85M 4.77%
94,775
+8,700
+10% +$577K
2022 Q4
4 quarters
SCI icon
11
Service Corp International
SCI
$10.5B
$7.65M 4.65%
111,746
– –
2021 Q4
8 quarters
WST icon
12
West Pharmaceutical
WST
$25.8B
$7.33M 4.46%
20,827
– –
2021 Q4
8 quarters
BFAM icon
13
Bright Horizons
BFAM
$3.38B
$6.82M 4.15%
72,396
– –
2021 Q4
8 quarters
TRMB icon
14
Trimble
TRMB
$14B
$6.41M 3.89%
120,416
– –
2021 Q4
8 quarters
APH icon
15
Amphenol
APH
$215B
$5.88M 3.58%
237,460
-11,200
-5% -$247K
2021 Q4
8 quarters
JKHY icon
16
Jack Henry & Associates
JKHY
$10.5B
$5.88M 3.57%
36,000
– –
2023 Q1
3 quarters
NSP icon
17
Insperity
NSP
$1.86B
$5.12M 3.11%
43,705
– –
2021 Q4
8 quarters
BBSI icon
18
Barrett Business Services
BBSI
$769M
$4.58M 2.79%
158,352
-42,000
-21% -$1.08M
2021 Q4
8 quarters
HEI.A icon
19
HEICO Corp Class A
HEI.A
$31.2B
$4.56M 2.77%
32,030
+5,000
+18% +$677K
2021 Q4
8 quarters
RGP icon
20
Resources Connection
RGP
$98.2M
$4.12M 2.5%
290,485
+14,000
+5% +$196K
2021 Q4
8 quarters
HEI icon
21
HEICO Corp
HEI
$41.7B
$4.01M 2.44%
22,433
– –
2021 Q4
8 quarters
MRVI icon
22
Maravai LifeSciences
MRVI
$1.11B
$2.65M 1.61%
404,900
+45,600
+13% +$295K
2022 Q4
4 quarters

Similar funds

Alpine Peaks Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Alpine Peaks Capital held 22 positions worth $165M, up 15% from $143M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Alpine Peaks Capital opened no new positions and made no exits, leaving the 22-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

  • Alpine Peaks Capital added most to Cognex in Q4 2023, an estimated $1.4M increase.
  • Alpine Peaks Capital's biggest Q4 2023 reduction was Qualys, cutting an estimated $1.38M.
  • Alpine Peaks Capital's ten largest holdings make up 60% of its $165M portfolio in Q4 2023.
  • Alpine Peaks Capital opened 0 new positions and closed 0 in Q4 2023.
  • Alpine Peaks Capital's portfolio value rose 15% quarter-over-quarter to $165M.

Based on Alpine Peaks Capital's 13F filing for Q4 2023, filed 14 Feb 2024.